Organization: Institute for Research in Immunology and Cancer — Commercialization of Research

Five CECRs receive $78.9 million in new funding in competition geared towards existing centres

The federal government has finally announced the results of last year’s competition for existing Centres of Excellence for Commercialization and Research (CECR), with five returning centres sharing $78.9 million over five years. The successful CECRs were chosen from a field of 25 letters of intent and 10 full applications, all of which were previously or are currently receiving funding through the program.

Research identifies small molecule drug candidate

The Univ of Montreal‘s Institute for Research in Immunology and Cancer, the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) and Bristol Myers Squibb, have identified a small molecule drug candidate against a novel target. The discovery triggers a milestone payment to U of M and validates IRICoR’s business model of…

Three CECRs receive $4 million from Merck Canada

Merck Canada is investing $4 million in three Centres of Excellence for Commercialization and Research (CECR) as part of a $100-million commitment it made in 2010 when it closed its Merck Frosst Centre for Therapeutic Research in a global restructuring (R$, July 19/10). The funding goes to the Institute for Research in Immunology and Cancer…